메뉴 건너뛰기




Volumn 96, Issue 3, 2012, Pages 342-349

Acute myeloid leukemia in clinical practice: A retrospective population-based cohort study in Miyazaki Prefecture, JPN

(27)  Matsunaga, Takuya a,b   Yamashita, Kiyoshi c   Kubuki, Yoko a   Toyama, Takanori d   Imataki, Osamu b   Maeda, Kouichi e   Kawano, Noriaki c,g   Satou, Seiichi f   Kawano, Hiroshi a   Ishizaki, Junzo h   Yoshida, Shuro c   Kameda, Takuro a   Sasaki, Tadashi d   Sekine, Masaaki a   Kamiunten, Ayako a   Taniguchi, Yasuhiro a   Hidaka, Tomonori a   Katayose, Keiko a   K Shimoda, Haruko a   Shide, Kotaro a   more..


Author keywords

Acute myeloid leukemia (AML); Clinical practice; Populationbased study

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL PRACTICE; COHORT ANALYSIS; FEMALE; GENETIC RISK; HUMAN; JAPAN; KARYOTYPE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY;

EID: 84866995946     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1146-2     Document Type: Article
Times cited : (7)

References (31)
  • 2
    • 29244475038 scopus 로고    scopus 로고
    • The treatment of AML: Current status and novel approaches
    • Burnett AK. The treatment of AML: current status and novel approaches. Hematology. 2005;10(Suppl 1):50-3.
    • (2005) Hematology , vol.10 , Issue.SUPPL. 1 , pp. 50-53
    • Burnett, A.K.1
  • 3
    • 0033619959 scopus 로고    scopus 로고
    • Underrepresentation of patients 65 years of age or older in cancer - Treatment trials
    • Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer- treatment trials. N Engl J Med. 1999;341:2061-7.
    • (1999) N Engl J Med , vol.341 , pp. 2061-2067
    • Hutchins, L.F.1    Unger, J.M.2    Crowley, J.J.3    Coltman, C.A.4    Albain, K.S.5
  • 4
    • 0032939412 scopus 로고    scopus 로고
    • A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: Karyotypic features in relation to morphology, age and gender
    • Mauritzson N, Johansson B, Albin M, Billstrom R, Ahlgren T, Mikoczy Z, et al. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol. 1999;62:95-102.
    • (1999) Eur J Haematol , vol.62 , pp. 95-102
    • Mauritzson, N.1    Johansson, B.2    Albin, M.3    Billstrom, R.4    Ahlgren, T.5    Mikoczy, Z.6
  • 5
    • 66149148673 scopus 로고    scopus 로고
    • Age and acute myeloid leukemia: Real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
    • Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113:4179-87.
    • (2009) Blood , vol.113 , pp. 4179-4187
    • Juliusson, G.1    Antunovic, P.2    Derolf, A.3    Lehmann, S.4    Mollgard, L.5    Stockelberg, D.6
  • 6
    • 0028925154 scopus 로고
    • De novo acute myeloid leukaemia in patients over 55-yearsold: A population-based study of incidence, treatment and outcome
    • Northern Region Haematology Group
    • Taylor PR, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ. De novo acute myeloid leukaemia in patients over 55-yearsold: a population-based study of incidence, treatment and outcome. Northern Region Haematology Group. Leukemia. 1995;9: 231-7.
    • (1995) Leukemia , vol.9 , pp. 231-237
    • Taylor, P.R.1    Reid, M.M.2    Stark, A.N.3    Bown, N.4    Hamilton, P.J.5    Proctor, S.J.6
  • 7
    • 68949207957 scopus 로고    scopus 로고
    • The incidence of and mortality from leukaemias in the UK: A general population-based study
    • Bhayat F, Das-Gupta E, Smith C, McKeever T, Hubbard R. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer. 2009;9:252.
    • (2009) BMC Cancer , vol.9 , pp. 252
    • Bhayat, F.1    Das-Gupta, E.2    Smith, C.3    McKeever, T.4    Hubbard, R.5
  • 8
    • 33750020532 scopus 로고    scopus 로고
    • The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England
    • Phekoo KJ, Richards MA, Moller H, Schey SA. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica. 2006;91:1400-4.
    • (2006) Haematologica , vol.91 , pp. 1400-1404
    • Phekoo, K.J.1    Richards, M.A.2    Moller, H.3    Schey, S.A.4
  • 9
    • 42149096533 scopus 로고    scopus 로고
    • Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century
    • Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica. 2008;93:594-600.
    • (2008) Haematologica , vol.93 , pp. 594-600
    • Pulte, D.1    Gondos, A.2    Brenner, H.3
  • 10
    • 0033984685 scopus 로고    scopus 로고
    • Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: A comparative study of Australian and Japanese adult cases
    • Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K, et al. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia. 2000;14:163-8.
    • (2000) Leukemia , vol.14 , pp. 163-168
    • Nakase, K.1    Bradstock, K.2    Sartor, M.3    Gottlieb, D.4    Byth, K.5    Kita, K.6
  • 11
    • 84874022967 scopus 로고    scopus 로고
    • NCCN, Accessed Aug 28 2010
    • NCCN. Guideline. http://www.nccn.org/professionals/physician-gls/f- guidelines.asp. Accessed Aug 28 2010.
    • Guideline.
  • 12
    • 84863756326 scopus 로고    scopus 로고
    • BCSH, Accessed Aug 28 2010
    • BCSH. Guidelines. http://www.bcshguidelines.com/guidelinesMENU.asp. Accessed Aug 28 2010.
    • Guidelines
  • 13
    • 0032188805 scopus 로고    scopus 로고
    • The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
    • The Medical Research Council Adult and Children's Leukaemia Working Parties
    • Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92:2322-33.
    • (1998) Blood , vol.92 , pp. 2322-2333
    • Grimwade, D.1    Walker, H.2    Oliver, F.3    Wheatley, K.4    Harrison, C.5    Harrison, G.6
  • 14
    • 0034672269 scopus 로고    scopus 로고
    • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study
    • Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood. 2000;96:4075-83.
    • (2000) Blood , vol.96 , pp. 4075-4083
    • Slovak, M.L.1    Kopecky, K.J.2    Cassileth, P.A.3    Harrington, D.H.4    Theil, K.S.5    Mohamed, A.6
  • 15
    • 0037114753 scopus 로고    scopus 로고
    • Pretreatment cytogenetic abnormalities are predictive of induction success cumulative incidence of relapse and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461)
    • Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100:4325-36.
    • (2002) Blood , vol.100 , pp. 4325-4336
    • Byrd, J.C.1    Mrozek, K.2    Dodge, R.K.3    Carroll, A.J.4    Edwards, C.G.5    Arthur, D.C.6
  • 17
    • 70449647008 scopus 로고
    • Proportional hazard tests and diagnostic based on weighted residuals
    • Grambsch PTT. Proportional hazard tests and diagnostic based on weighted residuals. Biometrika. 1994;81:515-26.
    • (1994) Biometrika , vol.81 , pp. 515-526
    • Grambsch, P.T.T.1
  • 19
    • 0031961755 scopus 로고    scopus 로고
    • Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    • Japan Adult Leukemia Study Group
    • Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol. 1998;16:78-85.
    • (1998) J Clin Oncol , vol.16 , pp. 78-85
    • Asou, N.1    Adachi, K.2    Tamura, J.3    Kanamaru, A.4    Kageyama, S.5    Hiraoka, A.6
  • 20
    • 9444297295 scopus 로고    scopus 로고
    • All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia
    • Sanz MA, Vellenga E, Rayon C, Diaz-Mediavilla J, Rivas C, Amutio E, et al. All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood. 2004;104:3490-3.
    • (2004) Blood , vol.104 , pp. 3490-3493
    • Sanz, M.A.1    Vellenga, E.2    Rayon, C.3    Diaz-Mediavilla, J.4    Rivas, C.5    Amutio, E.6
  • 22
    • 0035469883 scopus 로고    scopus 로고
    • The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): Analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
    • Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood. 2001;98: 1312-20.
    • (2001) Blood , vol.98 , pp. 1312-1320
    • Grimwade, D.1    Walker, H.2    Harrison, G.3    Oliver, F.4    Chatters, S.5    Harrison, C.J.6
  • 24
    • 0035760320 scopus 로고    scopus 로고
    • Dependence of age-specific incidence of acute myeloid leukemia on karyotype
    • Schoch C, Kern W, Krawitz P, Dugas M, Schnittger S, Haferlach T, et al. Dependence of age-specific incidence of acute myeloid leukemia on karyotype. Blood. 2001;98:3500.
    • (2001) Blood , vol.98 , pp. 3500
    • Schoch, C.1    Kern, W.2    Krawitz, P.3    Dugas, M.4    Schnittger, S.5    Haferlach, T.6
  • 25
    • 0031893746 scopus 로고    scopus 로고
    • Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia
    • Ferrara F, Annunziata M, Copia C, Magrin S, Mele G, Mirto S. Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemia. Haematologica. 1998;83:126-31.
    • (1998) Haematologica , vol.83 , pp. 126-131
    • Ferrara, F.1    Annunziata, M.2    Copia, C.3    Magrin, S.4    Mele, G.5    Mirto, S.6
  • 26
    • 0036369348 scopus 로고    scopus 로고
    • Prognosis of elderly patients with acute myelogenous leukemia: Analysis of 126 AML cases
    • Iwakiri R, Ohta M, Mikoshiba M, Tsutsumi H, Kumakawa T, Mori M. Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases. Int J Hematol. 2002;75: 45-50.
    • (2002) Int J Hematol , vol.75 , pp. 45-50
    • Iwakiri, R.1    Ohta, M.2    Mikoshiba, M.3    Tsutsumi, H.4    Kumakawa, T.5    Mori, M.6
  • 27
    • 54849436885 scopus 로고    scopus 로고
    • Prognositic factors in elderly patients with AML and the implications for treatment
    • Erba HP. Prognositic factors in elderly patients with AML and the implications for treatment. In: American Society of Hematology Education Program Book; 2007. p. 420-428.
    • (2007) American Society of Hematology Education Program Book , pp. 420-428
    • Erba, H.P.1
  • 28
    • 0028889993 scopus 로고
    • Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia
    • European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups
    • Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med. 1995;332:217-23.
    • (1995) N Engl J Med , vol.332 , pp. 217-223
    • Zittoun, R.A.1    Mandelli, F.2    Willemze, R.3    De Witte, T.4    Labar, B.5    Resegotti, L.6
  • 29
    • 0036036741 scopus 로고    scopus 로고
    • The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial
    • Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH, et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol. 2002;118: 385-400.
    • (2002) Br J Haematol , vol.118 , pp. 385-400
    • Burnett, A.K.1    Wheatley, K.2    Goldstone, A.H.3    Stevens, R.F.4    Hann, I.M.5    Rees, J.H.6
  • 30
    • 77950917665 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: Results of the JALSG AML97 study
    • Sakamaki H, Miyawaki S, Ohtake S, Emi N, Yagasaki F, Mitani K, et al. Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study. Int J Hematol. 2010;91:284-92.
    • (2010) Int J Hematol , vol.91 , pp. 284-292
    • Sakamaki, H.1    Miyawaki, S.2    Ohtake, S.3    Emi, N.4    Yagasaki, F.5    Mitani, K.6
  • 31
    • 79952133594 scopus 로고    scopus 로고
    • A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: The JALSG AML201 Study
    • Miyawaki S, Ohtake S, Fujisawa S, Kiyoi H, Shinagawa K, Usui N, et al. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study. Blood. 2011;117:2366-72
    • (2011) Blood , vol.117 , pp. 2366-2372
    • Miyawaki, S.1    Ohtake, S.2    Fujisawa, S.3    Kiyoi, H.4    Shinagawa, K.5    Usui, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.